Elanix Teams With Dermacon To Develop New Wound-Care Devices
Executive Summary
Swiss start-up Elanix Biotechnologies has signed an agreement with German firm Dermacon GmbH to develop progenitor cell medical devices for wound healing. Elanix has set its sights for a 2020 European launch of the devices.